APA (7th ed.) Citation

Febri Wulandari, Muthi' Ikawati, Dhania Novitasari, Mitsunori Kirihata, Jun-ya Kato, & Edy Meiyanto. (2020). New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells. Universitas Gadjah Mada.

Chicago Style (17th ed.) Citation

Febri Wulandari, Muthi' Ikawati, Dhania Novitasari, Mitsunori Kirihata, Jun-ya Kato, and Edy Meiyanto. New Curcumin Analog, CCA-1.1, Synergistically Improves the Antiproliferative Effect of Doxorubicin Against T47D Breast Cancer Cells. Universitas Gadjah Mada, 2020.

MLA (9th ed.) Citation

Febri Wulandari, et al. New Curcumin Analog, CCA-1.1, Synergistically Improves the Antiproliferative Effect of Doxorubicin Against T47D Breast Cancer Cells. Universitas Gadjah Mada, 2020.